|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 47/68 | (nenurodyta) |
| A61P 35/00 | (nenurodyta) |
| (11) | Number of the document | 2906253 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13795435.0 |
| Date of filing the European patent application | 2013-10-11 | |
| (97) | Date of publication of the European application | 2015-08-19 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-01 |
| (46) | Date of publication of the claims translation | 2018-10-10 |
| (86) | Number | PCT/EP2013/071341 |
| Date | 2013-10-11 |
| (87) | Number | WO 2014/057113 |
| Date | 2014-04-17 |
| (30) | Number | Date | Country code |
| 201261712924 P | 2012-10-12 | US | |
| 201261712928 P | 2012-10-12 | US | |
| 201361784525 P | 2013-03-14 | US | |
| 201361784460 P | 2013-03-14 | US | |
| 201361784477 P | 2013-03-14 | US |
| (72) |
VAN BERKEL, Patricius Hendrikus Cornelis, CH
HOWARD, Philip Wilson, GB
|
| (73) |
Medimmune Limited,
Milstein Building Granta Park, Cambridge, Cambridgeshire CB21 6GH,
GB
ADC Therapeutics SA, Route de la Corniche 3B, 1066 Epalinges, CH |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pirolobenzodiazepino-anti-PSMA antikūno konjugatas |
| PYRROLOBENZODIAZEPINE - ANTI-PSMA ANTIBODY CONJUGATES |
| Payment date | Validity (years) | Amount | |
| 2019-10-01 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-10-11 |